Multifocal extramural venous invasion is a powerful predictor of adverse oncological outcomes in stages I– III colorectal cancer
Rattachement africain : tr, ca, ae. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
AIMS: This study aimed to determine the impact of venous invasion (VI) characteristics on oncological outcomes in colorectal cancer (CRC). METHODS AND RESULTS: Resection specimens from 368 patients with TNM stages I-III CRC were assessed for VI including its presence/absence, location [intramural (IMVI) or extramural (EMVI)], number and size of the largest VI focus. VI and EMVI were identified in 55% and 32% of cases, respectively. EMVI, but not IMVI, was significantly associated with decreased 5-year recurrence-free survival (RFS) and disease-specific survival (DSS) (hazard ratio [HR] 4.2, 95% confidence interval CI [2.6-6.9] and 3.7 [95% CI 1.9-6.9], p < 0.0001, respectively). Multifocal EMVI (mEMVI), defined as 2 or more EMVI foci, was identified in 67% of EMVI-positive cases. In multivariable analysis, EMVI (HR 2.4 [95% CI 1.3-4.3], P = 0.003) and mEMVI (HR 2.4 [95% CI: 1.3-4.4], P = 0.02) were independently associated with RFS and demonstrated stronger associations than all other examined features, including T and N stage. These associations were maintained when the cohort was expanded to include 113 patients who received neoadjuvant therapy in addition to the original 368 patients who had not ('expanded cohort', n = 481). An increasing number of EMVI foci was significantly associated with decreased RFS and DSS (P < 0.0001). Patients with >5 EMVI foci (n = 31) had a particularly poor prognosis with 5-year RFS and DSS of 29% and 56%, respectively. EMVI dimensions were not associated with oncological outcomes. CONCLUSIONS: Extramural location and multifocality are features of VI strongly associated with adverse oncological outcomes. If externally validated, incorporation of EMVI multifocality into future reporting protocols merits consideration.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.
- Titre Crossref
- Multifocal extramural venous invasion is a powerful predictor of adverse oncological outcomes in stages I– <scp>III</scp> colorectal cancer
- Date Crossref
- 27/08/2025
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.